Navigation Links
Doctor Grilled In Court For False Report About Vioxx Health Risk

The doctor, who had dismissed increased risk of heart attack associated with Vioxx, has been accused by lawyers who argue that his views are 'out of the mainstream' as it is based on biased research //, funded by the drug company, Merck and Co.

Thomas Cona and John Mcdarby have sued the pharmaceutical company, stating that use of the drug had resulted in heart attacks. More than 10, 000 different lawsuits has been filed against the controversial Vioxx, on grounds of product liability. The product, originally intended for arthritis treatment was withdrawn from the market in the September of 2004.

The case was taken up for hearing recently. Attorney Mark Lanier questioned the motivation and educational qualifications of Merck expert witness Dr. Barry Rayburn during the cross-examination. He works as a cardiologist in the University of Alabama. He further stated that anyone who had not taken money from Merck would deserve to be called mainstream doctor.

The attorney who stands for Thomas Cona is the only who had won a case against Merck, last August. He enabled a Texas based widow, a user of Vioxx receive a multimillion-dollar jury award. Other similar trials that were taken up in the state and federal courts had ended up in favor of Merck.

Rayburn was peppered with questions about studies and articles that demonstrated an increased risk of heart attack in those who used Vioxx. This however was not included in the doctor’s testimony that was submitted in the court on Tuesday. To this Rayburn responded by saying that some of the articles or studies cited by Lanier were not included in his testimony because he 'felt it was important to look at things that were peer reviewed. I also looked at many studies we have not talked about'.

The close scrutiny by several other experts in a specific field confers the peer-reviewed studies, a higher credibility. Every attempt is made to ensure that the study was indeed desig ned and conducted in a systematic way, to meet the industry standards. The cardiologist pointed out to the study conducted on more than 28, 000 patients that had no evidence of increased heart attack or other cardiovascular complications.

In addition, Rob Gordon, a lawyer representing McDarby, grilled Rayburn about his legal work for Merck, his payment and involvement in other clinical trials conducted by the drug company.

Following a study, which showed for the first time that use of the drug for a period of 18 months, doubled the heart attack risk; the pain relief was withdrawn from the drug market.

The conclusion, according to the lawyers is that although it was known that the drug increased risk of heart attacks in users, the drug company failed to warn the users, compromising on patient safety for want of profit.


'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Indian Doctor granted US patent on organ regeneration
7. Emphasis to ban Drugs ads by Doctors
8. Doctor samples come under the ambit of advertisement
9. Doctors not to accept gifts from drug companies
10. Gene testing kit specific for Doctors
11. Doctors warned of fluoride toxicity
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... 28, 2017 , ... Accreditation Commission for Health Care (ACHC) ... America (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s ... Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much more than ... (NSF), going just 19 hours without sleep can compromise motor reaction time, which can increase ... and Amica Insurance is sharing the following tips from the NSF to help you sleep ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery ... the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, ... patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... People are ... older people. “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa ... Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions ... Grove Foundation implement a Microsoft Dynamics GP solution that integrates to their PointClickCare ... that specializes in long-term care, Brooke Grove now has the capability to achieve ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
Breaking Medicine Technology: